Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Network
Plants & 20 workshops
Research & Development
Labs, ATMP & formulation
Quality & GMP
Standards & traceability
Alliance Stem Cell Centre
Stem-cell, NK & exosome science
Integrated Value Chain
Farm → chemicals → finished
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
JOINT VENTURE
International
5 Jan 2026 · Cambodia

PHANNTHAMIT Co., Ltd

A 50/50 joint venture with Mane Group to bring trusted medicines to all 25 provinces of Cambodia.

Alliance and Mane Group executives at the PHANNTHAMIT joint venture signing in Phnom Penh

On 5 January 2026 in Phnom Penh, Alliance — Laos Alliance Pharmaceutical Group — and Mane Group of Cambodia signed a 50/50 joint venture to establish PHANNTHAMIT, a new pharmaceutical and healthcare distribution company for the Kingdom of Cambodia.

The venture pairs Alliance’s manufacturing capacity and technical know-how with Mane Group’s infrastructure, distribution reach and regulatory network in Cambodia. The signing ceremony was witnessed by Cambodia’s Department of Drugs and Food (Ministry of Health) and the President of the Pharmacy Association of Cambodia.

PHANNTHAMIT will serve all 25 provinces and Phnom Penh through a pharmacy-first model, starting with essential generics and hospital medicines backed by structured quality assurance and compliance. Operations are expected to begin in 2026, following product registration, packaging redesign, barcode compliance and bilingual patient information leaflets.

Looking further ahead, the partners plan to explore a PHANNTHAMIT pharmaceutical factory in Cambodia, and share a longer-term vision for a stem-cell clinic and an international hospital — positioning PHANNTHAMIT as a Cambodian brand with ASEAN ambitions.

Trusted Medicines, Better Lives.

Signed
5 January 2026
Location
Phnom Penh, Cambodia
Partner
Mane Group (Cambodia)
Reach
25 provinces + Phnom Penh
Focus
Trusted, high-quality medicines for the Kingdom of Cambodia
Operations begin
2026
Signing of the PHANNTHAMIT joint venture agreement, Phnom Penh, January 2026
Alliance and Mane Group representatives at the PHANNTHAMIT signing ceremony
Officials witnessing the PHANNTHAMIT joint venture signing in Phnom Penh

Photos: signing ceremony. Source: Fresh News.

Visit us

Corporate headquarters

No. 46, Street 348 BKK3, Phnom Penh, Cambodia

More partnerships

Mesk for Trading (MTA) logo
DISTRIBUTORS
International

Mesk for Trading (MTA)

Distribution partner. Partnership details coming soon.

Related news

ALI-LENA Injection (lenacapavir) 463.5 mg / 1.5 mL vial product packaging
Product news
15 Jul 2026

ALI-LENA® Injection (lenacapavir) registered in Lao PDR

The Food and Drug Department has registered ALI-LENA® Injection (lenacapavir) 463.5 mg / 1.5 mL for subcutaneous use, indicated with other antiretrovirals for heavily treatment-experienced adults with multidrug-resistant HIV-1.
Alliance Pharma Group — six-month achievements 2026
Company
1 Jul 2026

A Driving Force in Southeast Asian Pharmaceutical Manufacturing

Alliance’s first-half 2026 highlights, from ASEAN expansion to advanced biopharmaceutical manufacturing.
Two cartons and an injection pen labelled ALI-TIRZEP 5mg, overprinted with a banner reading Confirmed Counterfeit — For Disposal Only
Product Safety
24 Jun 2026

Official Notice Regarding Counterfeit ALI-TIRZEP® Products

Alliance Pharmaceutical Co., Ltd. has identified counterfeit products being distributed under the ALI-TIRZEP® name. How to identify them, how to verify genuine product, and how to report a suspected counterfeit.
Become a partner
EN·ລາວ·中文